Brisbane clinic offering new pain-free breast screen technology
Your web browser is no longer supported. To improve your experience update it here Pain-free breast cancer CT scans are now being offered for the first time in Australia. Conventional mammograms require compressing the breast which can be painful, particularly for women with dense breasts. However, Cone Beam Breast CT offers a pain free alternative, and experts using it say it gives superior clarity, particularly for women with dense breasts. Pain-free breast cancer CT scans are now being offered for the first time in Australia. (9News) About a third of Australian women over 50 have dense breasts and about 25 per cent of women under the age of 50 have extremely dense breasts. The new technology is approved by the FDA in the United States with registration pending in Australia. Breast screening patient Belinda Yates got access through the TGA's special access scheme and said it's a completely different experience to mammograms. "Firstly there's no pain associated with the scan... there is no touching of your breast whatsoever," 46-year-old Yates said. "This was advised as a good test for me to have to see a clearer picture." Brisbane Radiology is the first clinic in Australia to use the technology after evaluating 10 years of research overseas. "It is really great for detecting small lesions with women with dense breasts and with complex breasts," Dr Jacqueline Milne said. "I honestly believe that this will change the paradigm for imaging in Australia, particularly for women with dense breasts." A contrast dye injection gives even greater visibility. "We wait two minutes and then the same scan is performed," she said. The scans can also be used to plan surgery to conserve the breast. "Women survive breast cancer now so we don't want to leave deformities," breast and endocrine surgeon Dr Ben Green said. "So having clarity about what tissue I need to remove, what volume of defect will be behind and how I'll fill that can result in less surgery, less need to come back and have further operations," he said. The emerging technology has an out of pocket cost of nearly $300 and is not part of the BreastScreen program, which provides free mammograms for women over 40. But the national body today posted new guidelines recommending for the first time that women are notified about their breast density. Queensland, Tasmania and the territories are yet to roll out the reporting system. Vicki Durston from the Breast Cancer Network wants all states and territories to adopt the standard. "We know 2D mammography can reduce sensitivity down to 64 per cent - so we want to see for those at high risk or those with high breast density - have the options of supplementary screening that is available for all," Durston said. A review by BreastScreen on the latest advances in screening technology is yet to be released. A spokesperson for the Department of Health, Disability and Ageing said: "At present, there is no consensus on the optimal screening pathway for those with increased mammographic density." However authorities stress mammograms detect the majority of breast cancers in Australia and remain the technology for mass screening for women of all breast densities. "Additional imaging tests are only available outside of the BreastScreen Australia program...and may incur out of pocket costs." Breast Cancer
national
health
Brisbane
queensland
tasmania CONTACT US
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
SBS Australia
17 hours ago
- SBS Australia
Lexi's genetic condition keeps her obese. But her family can't afford life-changing medication
Lexi's genetic disorder, which keeps her constantly hungry, has rendered her bariatric surgery ineffective. So she's hoping weight-loss drugs could help her. Source: SBS / Colin Cosier for Dateline Watch Dateline's documentary 'Born Big' on 3 June at 9.30pm on SBS or SBS On Demand. By her 12th birthday, Lexi weighed 116kg — almost three times the average weight of an American girl her age. By the time she turned 13, she had 80 per cent of her stomach removed through bariatric surgery. She initially lost 29kg . But nine months after the operation, she regained some weight, and her intense hunger returned. Lexi has MC4R gene deficiency. It disrupts the brain's ability to regulate appetite, resulting in weight gain and a constant feeling of insatiable hunger. Nearly three years after her surgery, Lexi, now 15, is exploring alternative options. "I'd like to be a size where I can go out and play sports again, like I used to when I was younger," she says. She was recently prescribed Wegovy, a weight-loss medication approved by the US Food and Drug Administration (FDA) for treatment of obesity in people aged 12 and older. Wegovy belongs to the new class of injectable medications, originally used for the treatment of Type 2 diabetes but now FDA-approved for long-term weight management. These drugs — primarily semaglutide (Wegovy and Ozempic) and tirzepatide (marketed under the brand names Mounjaro and Zepbound) — mimic GLP-1 hormones that regulate blood sugar and appetite, helping patients feel fuller for longer. They have been popularised by celebrities and on social media. According to a 2024 study published in the Journal of the American Medical Association , prescriptions of these drugs for teens and young adults in the United States increased by 600 per cent between 2020 and 2023 — with the overwhelming majority being teenage girls. One in five children and adolescents in the US are affected by obesity. In January 2023, the American Academy of Pediatrics (AAP), the largest professional association of paediatricians in the US, updated its guidelines for treating children with obesity — for the first time in 15 years. It now recommends early medical interventions such as surgery and weight-loss drugs, in addition to lifestyle and behaviour changes. Dr Fatima Cody Stanford, an obesity medicine physician and an associate professor at Harvard Medical School, says there's been "a noticeable shift in recent years in how obesity and obesity medications are discussed within the paediatric and broader medical fields". "There is growing recognition of obesity as a complex, chronic disease rather than a simple consequence of lifestyle choices," she says. "The increasing visibility and acceptance of pharmacological treatments as legitimate components of obesity management reflect this change, although stigma still exists and must be continually addressed." However, she says irreversible treatment such as bariatric surgery and indefinite use of medication at age 12 "must be approached with caution". It's important to balance the potential benefits of anti-obesity drugs against the unknown long-term effects, she says. "I advise families to consider the improvement in quality of life and reduction in obesity-related health risks as significant benefits," she says. "However, the psychological and emotional aspects, such as body image, potential dependence on medication, and identity formation, should be openly discussed." Lexi's mum Brandy was initially against injectable GLP-1 drugs. "I wanted her to be a little older," she says. Now, looking back, she says she would have started with medication rather than surgery for Lexi. "Surgery is final ... there's no reversing it," she says, adding that she believes bariatric surgery remains an essential option if other treatments fall short. Bariatric surgery usually leads to substantial weight loss, but Lexi's MC4R deficiency made her procedure far less effective. "The conversation is changing," Brandy says. "I remember the first weight loss hospital we went to, they literally just gave us a portion plate and sent us home." Now, "the availability and the options for people, it's great, [and] it needs to keep going." In April, Lexi was prescribed Wegovy. But the family has been locked in a battle with their insurance provider to secure even partial coverage for the medication's cost. Despite more weight-loss drugs hitting the market, many people in the US still can't afford them. A month's supply of Wegovy, for example, can cost approximately US$1,350 ($2,100) — that's over US$16,000 ($25,000) each year. Medicare, the federal health insurance, is prohibited from covering weight-loss drugs by law. Most private health plans don't cover them either, primarily, due to their high cost. Bariatric surgery, on the other hand, is covered by insurance companies. In April, the Trump administration rejected a Biden-era proposal to expand Medicare coverage of anti-obesity drugs such as Wegovy. However, GLP-1 drugs have become a target of a new executive order, signed by US President Donald Trump in May, aimed at lowering prescription drug prices, which are notoriously high in the US compared to other developed nations. In the meantime, Lexi has seen some progress with an oral appetite suppressant, Qsymia, to help regulate her hunger. She's lost weight and had her obesity reduced from class 3 to class 2. But the journey has been mentally draining, she says. "You just feel kind of defeated because , you're like, ' what am I supposed to do when my options run out?" Watch now
Sydney Morning Herald
a day ago
- Sydney Morning Herald
Tom's plan was to get a degree in Sydney. It went horribly wrong
After finishing high school, Chinese international student Tom considered university study in the United States. But, after seeing pictures of Australian beaches and the Opera House on social media, he enrolled in a degree in Sydney. He did not realise that, within months of arriving, he would find himself homeless for the first time, trying to sleep in a park underneath the Harbour Bridge. 'I was so tired, but I cannot sleep because I was hungry and freezing,' Tom said. That was in February 2024. After more than a year, he's become accustomed to sleeping in parks. Tom's story is an increasingly common one, according to the city's homelessness services, who say international students are increasingly finding themselves without a place to live. Nurse unit manager at St Vincent's Hospital's homeless health service Erin Longbottom said international students were becoming the hidden face of homelessness. 'No one is talking about it,' she said. They prefer to sleep in well-lit areas, she said, such as train stations or near public libraries. 'We have, at times, a build up of people in car parks where they can charge their electric bikes as that's where they work [doing] food delivery,' she said.
The Age
a day ago
- The Age
Tom's plan was to get a degree in Sydney. It went horribly wrong
After finishing high school, Chinese international student Tom considered university study in the United States. But, after seeing pictures of Australian beaches and the Opera House on social media, he enrolled in a degree in Sydney. He did not realise that, within months of arriving, he would find himself homeless for the first time, trying to sleep in a park underneath the Harbour Bridge. 'I was so tired, but I cannot sleep because I was hungry and freezing,' Tom said. That was in February 2024. After more than a year, he's become accustomed to sleeping in parks. Tom's story is an increasingly common one, according to the city's homelessness services, who say international students are increasingly finding themselves without a place to live. Nurse unit manager at St Vincent's Hospital's homeless health service Erin Longbottom said international students were becoming the hidden face of homelessness. 'No one is talking about it,' she said. They prefer to sleep in well-lit areas, she said, such as train stations or near public libraries. 'We have, at times, a build up of people in car parks where they can charge their electric bikes as that's where they work [doing] food delivery,' she said.
